Sun Pharma launches Chericof® 12 in India, a novel formulation that provides relief from cough for up to 12 hours

By -

 Polistirex technology provides sustained release of the medicine

Mumbai, September 28, 2021: Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” and includes its subsidiaries and/or associate companies) today announced the launch of a novel formulation in cough management - Chericof® 12 (Dextromethorphan Hydrobromide 30 mg and Chlorpheniramine Maleate 4 mg) in India. Chericof® 12, the first prescription cough syrup in India which gives relief for up to 12 hours, is manufactured using Polistirex technology for sustained release of the drug. Chericof® 12 is approved for patients of age group six years and above.

 

All cough syrups generally give relief for 6-8 hours, and hence a patient has to take it three to four times a day. Frequent dosing often leads to patient inconvenience and non-adherence to follow the regimen, which may compromise the efficacy of the medication and disturb the daily lifestyle. As per a study, a twice-a-day dosing regimen was associated with significantly better compliance in 70% of patients than three-times a day (52%) and four-times a day (42%) dosing regimen, respectively1. The Polistirex technology used in Chericof® 12 provides sustained release of the medicine in the body, thus offering up to 12 hour relief to patients with twice-daily dosage.

 

Kirti Ganorkar, CEO – India Business, Sun Pharma said “At Sun Pharma, we always endeavour to introduce differentiated medicines that enhance convenience or solve patients’ problems, thus helping them to cope better with their ailments. The Polistirex technology used in Chericof® 12 helps in improving patient compliance and avoids the need for frequent dosing.” 

 

Polistirex Technology involves the complexation of two drugs, Dextromethorphan Hydrobromide and Chlorpheniramine maleate with resins. The resin granules of both drugs are added in suspension to form Chericof® 12. Complexation of drugs with polistirex not only provides sustained release but also masks the bitter taste making it more palatable.

 

Chericof® 12 is a prescription product and should only be taken on the doctor’s advice.

 

Reference

1.       Overview of patient compliance with medication dosing: a literature review Greenberg  R.N. Clin Ther 1984;6(5):592-9 available at https://pubmed.ncbi.nlm.nih.gov/6383611/

Comments

Post a Comment

Popular posts from this blog

QNet launches New Luxury Chairos Watches

By -
Image
·           Five new luxury watches  - Alpine Neo, Vector,  Crusader, Aquatica and Latitude launched in India under Chairos brand ·           Price range of the new collection is from Rs 62,000 to Rs 1,00,000 New Delhi, February 12  2018 :   Leading Asian direct selling company QNet has launched five new models under its luxury watch brand - Chairos. The Chairos brand is QNet’s proprietary range of luxury and sports watches exclusively for India. The new Chairos watches have been designed to combine form and functionality with timeless elegance and style. Commenting on the launch of the new range of watches, Trevor Kuna, Global CEO of QNet said, “Men typically don’t have many options for accessories to splurge on and watches have been known to convey a subtle message about the wearer’s personality. India is a fast growing global economy and more men are turning to active lifestyles, travel and exploring new experiences. Chairos is our flagship brand in India and we want
Read more

नान- शूगर स्वीटनरज़ प्रसिद्ध हो गए हैं: एफ आई सी सी आई सेमीनार मिथ को खत्म करता है और कम कैलरी वाले स्वीटनरज़ के स्वास्थ्य लाभों के बारे में बताता है

By -
मुंबई , 22  जून  2023:   एफ आई सी सी आई ने आज एक सेमीनार को आयोजित किया जिसमें  WHO NUGAG  निर्देशों के बारे में बताया हया जो की नान – शूगर स्वीटनरज़ (एन एस एस) के इस्तेमाल के साथ सम्बंधित हैं।  सेमीनार में आधुनिक विज्ञान सबूत और विश्व स्वास्थ्य संस्था (डब्ल्यू एच ओ) और प्रमुख भारतीय माहिरों के सुझावों की समीक्षा दी गई है। एफ आई सी सी आई ने कार्यवाही की मुख्य ज़रूरत को स्वीकार किया और उन उपायों को अपनाने पर जोर दिया जो ‘स्मार्ट विकल्पों ,  स्मार्ट लाभों और स्मार्ट भविष्य’ को प्रोत्साहित करते हैं।    इन्डियन काउंसिल आफ मेडिकल रिसर्च – इण्डिया डायबटीज़  (ICMR-INDIAB)  द्वारा किये गए हालिया अध्ययन के अनुसार ,  जो यह पुष्टि करता है कि भारत में 101 मिलियन डायबटीज़ के मरीज़ हैं ,  जिससे भारत आज एक डायबेटिक राष्ट्र बन गया है। मेडिकल ,  न्यूट्रीशनल ,  और विज्ञान क्षेत्रों के मुख्य माहिरों के सम्बन्ध में ,  जिसमें  डाक्टर वी मोहन  पदम् श्री अवार्डी ,   डाक्टर बी सेसीकरन ,  डाक्टरमंगेश तिवास्क्र ,  डाक्टर राजीव चावला ,  डाक्टर जगमीत मदान ,  और डाक्टर पुलकित माथुर ,  ने सेमीनार में क्रियाशील तौर पर भा
Read more

Pension Adalat

By -
The Chief Postmaster General, Maharashtra Circle, Mumbai will be holding the 53rd Postal Pension Adalat for pensioners/family pensioners of Postal Department on 29th Sept 2023 at 11.00 Hrs, in the Office of Chief Postmaster General, Maharashtra Circle, Mumbai -400 001. Grievances regarding pensionary benefits pertaining to those who retired/died while in service from Department of Posts, Pensioners of Postal Department, Maharashtra and Goa States, which have not been settled within 3 months, will only be entertained in the Postal Pension Adalat.  Cases involving purely legal points i.e. succession, Notional pension, TBOP/MACP Promotion, stepping up of pay and disciplinary cases involving policy matters and cases pending for review of DPC will not be considered in Pension Adalat .  Pensioner should forward their grievance individually (not in bulk or on behalf of others) in triplicate in the proforma attached to Accounts Officer, Pension Adalat, O/o Chief Postmaster General, Maharashtr
Read more